Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
TKG Huchems Co., Ltd. (069260.KS)
KRW15,540.00
+350.00 (+2.30%)
KR KSC Basic Materials Chemicals - Specialty
Address
Namsan Square Building 4554
Seoul, KR
Seoul, KR
CEO
U-Chan Kim
Website
tkg.huchems.com
IPO
2002-10-08
ISIN KR7069260008
Description
TKG Huchems Co., Ltd. manufactures and sells fine chemical products in South Korea and internationally. It offers nitric acid, ammonium nitrate, mononitrobenzene, dinitrotoluene, and ammonia products. The company is also involved in the clean development mechanism business; and provision of urea solutions. The company was formerly known as Huchems Fine Chemical Corporation and changed its name to TKG Huchems Co.,Ltd. in March 2022. TKG Huchems Co.,Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW15,540.00
+350.00 (+2.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
185.9K
Beta
0.25
Float Shares
17.21M
Free Float %
44.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.05% | -6.59% | -3.68% | -12.91% | -6.54% | -6.90% | +5.79% | -24.61% | -23.25% | -13.04% | +766.58% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
15,540.00
DCF (Unlevered)
45,990.57
+195.9%
DCF (Levered)
37,404.97
+140.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | +1 |
| Buy | 1 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.15
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-5.1% Q1'26: +9.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-27.6% Q1'26: -9.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.5% ★ Q1'26: +8.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+5.8% Q1'26: +5.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.9% ★ Q1'26: +6.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+5.3% Q1'26: +2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.54× ★ Q1'26: 1.06× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
600.43B
est: 595.45B (+0.8%)
|
598.23B
est: 598.13B (+0.0%)
|
715.76B
est: 716.00B (0.0%)
|
762.88B
est: 762.90B (0.0%)
|
659.77B
est: 652.20B (+1.2%)
|
593.51B
est: 608.10B (-2.4%)
|
861.20B
est: 868.00B (-0.8%)
|
1.24T
est: 1.27T (-3.0%)
|
1.05T
est: 1.08T (-2.6%)
|
1.19T
est: 1.19T (+0.3%)
|
1.13T
est: 1.15T (-2.0%)
|
1.40T
1.39T – 1.42T
+21.9% YoY
|
1.41T
1.39T – 1.44T
+0.9% YoY
|
1.31T
1.30T – 1.33T
-7.1% YoY
|
| EBITDA |
88.68B
est: 89.56B (-1.0%)
|
103.51B
est: 89.97B (+15.1%)
|
185.52B
est: 107.70B (+72.3%)
|
173.52B
est: 114.75B (+51.2%)
|
143.78B
est: 98.10B (+46.6%)
|
111.81B
est: 91.47B (+22.2%)
|
137.04B
est: 130.56B (+5.0%)
|
135.19B
est: 191.55B (-29.4%)
|
179.01B
est: 162.50B (+10.2%)
|
148.66B
est: 158.70B (-6.3%)
|
119.45B
est: 154.04B (-22.5%)
|
187.81B
186.01B – 189.61B
+21.9% YoY
|
189.44B
185.79B – 193.10B
+0.9% YoY
|
175.96B
174.27B – 177.65B
-7.1% YoY
|
| EBIT |
49.87B
est: 69.11B (-27.8%)
|
69.33B
est: 69.43B (-0.1%)
|
155.38B
est: 83.11B (+87.0%)
|
144.39B
est: 88.55B (+63.1%)
|
115.37B
est: 75.70B (+52.4%)
|
80.54B
est: 70.58B (+14.1%)
|
107.15B
est: 100.75B (+6.3%)
|
108.03B
est: 147.82B (-26.9%)
|
153.64B
est: 125.40B (+22.5%)
|
102.15B
est: 119.17B (-14.3%)
|
65.62B
est: 115.68B (-43.3%)
|
141.04B
139.68B – 142.39B
+21.9% YoY
|
142.26B
139.52B – 145.01B
+0.9% YoY
|
132.14B
130.87B – 133.40B
-7.1% YoY
|
| Net Income |
36.63B
est: 33.66B (+8.8%)
|
43.12B
est: 39.42B (+9.4%)
|
114.39B
est: 108.00B (+5.9%)
|
104.50B
est: 98.78B (+5.8%)
|
70.36B
est: 71.99B (-2.3%)
|
49.59B
est: 58.94B (-15.9%)
|
75.66B
est: 72.06B (+5.0%)
|
81.71B
est: 128.54B (-36.4%)
|
134.78B
est: 127.84B (+5.4%)
|
77.66B
est: 86.10B (-9.8%)
|
59.91B
est: 74.97B (-20.1%)
|
65.61B
64.79B – 66.43B
-12.5% YoY
|
76.04B
65.06B – 87.01B
+15.9% YoY
|
52.12B
51.47B – 52.77B
-31.5% YoY
|
| SGA |
29.09B
est: 17.36B (+67.6%)
|
31.24B
est: 17.43B (+79.2%)
|
32.89B
est: 20.87B (+57.6%)
|
17.26B
est: 22.24B (-22.4%)
|
17.59B
est: 19.01B (-7.5%)
|
18.39B
est: 17.73B (+3.7%)
|
20.65B
est: 25.30B (-18.4%)
|
36.29B
est: 37.12B (-2.3%)
|
41.53B
est: 31.49B (+31.9%)
|
26.10B
est: 33.65B (-22.4%)
|
30.70B
est: 32.66B (-6.0%)
|
39.82B
39.44B – 40.21B
+21.9% YoY
|
40.17B
39.39B – 40.95B
+0.9% YoY
|
37.31B
36.95B – 37.67B
-7.1% YoY
|
| EPS |
933.00
est: 877.25 (+6.4%)
|
1,118.00
est: 1,027.33 (+8.8%)
|
2,985.00
est: 2,814.50 (+6.1%)
|
2,693.00
est: 2,574.40 (+4.6%)
|
1,811.57
est: 1,876.20 (-3.4%)
|
1,292.32
est: 1,536.00 (-15.9%)
|
1,971.81
est: 1,878.00 (+5.0%)
|
2,129.42
est: 3,350.00 (-36.4%)
|
3,512.00
est: 3,331.67 (+5.4%)
|
2,023.81
est: 2,131.00 (-5.0%)
|
1,465.49
est: 1,855.50 (-21.0%)
|
1,624.00
1,603.72 – 1,644.28
-12.5% YoY
|
1,882.00
1,610.33 – 2,153.67
+15.9% YoY
|
1,290.00
1,273.89 – 1,306.11
-31.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
72.97B
OE per share TTM
1,879.45
Owner's Yield
10.60%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
31.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 49 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.60% | 100.5K | 0.45% |
| 2 | Kodex 200 Mid-Small 226980.KS | 0.31% | 41.9K | 0.30% |
| 3 | First Trust Developed Markets ex-US Small Cap AlphaDEX Fund FDTS | 0.14% | 18.2K | 0.80% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.09% | 37.5K | 0.54% |
| 5 | WisdomTree Emerging Markets Equity Income UCITS ETF - Acc DEMR.L | 0.08% | 216.5K | 0.46% |
| 6 | WisdomTree Emerging Markets Equity Income UCITS ETF DEMD.L | 0.08% | 216.5K | 0.46% |
| 7 | Kodex Dividend Value 325020.KS | 0.06% | 52.0K | 0.30% |
| 8 | WisdomTree Emerging Markets High Dividend Fund DEM | 0.05% | 2.00M | 0.63% |
| 9 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.04% | 670.1K | 0.58% |
| 10 | Kodex 200 Intrinsic Value 223190.KS | 0.03% | 4.9K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
220.18M
Shares Outstanding
38.37M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Geom Sung Choi | Vice President & Director | — | male |
| Jong-Chan Park | Head of Sales Division & Deputy Director | — | male |
| Ju-Hwan Park | Senior MD, Chief Management Strategy Office & Director | — | male |
| Ki-Tae Jang | Senior MD, Head of Management Planning Division & Director | — | male |
| Woo-chan Kim | President | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 069260.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
